MedTrace Logo

A Clinical Study of Lyophilized Plasma in Patients on Warfarin

NCT01541098 · Status: WITHDRAWN · Phase: PHASE2 · Type: INTERVENTIONAL

Last updated 2015-03-18

No results posted yet for this study

Summary

This is a multi center, phase 2 randomized controlled study to determine the effect of lyophilized plasma in patients on warfarin therapy.

Conditions

  • Anticoagulant Therapy

Interventions

BIOLOGICAL

Lyophilized Plasma

Licensed plasma that has been lyophilized.

BIOLOGICAL

Licensed Plasma

Plasma that has been authorized for transfusion.

Sponsors & Collaborators

  • HemCon Medical Technologies, Inc

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-01-31
Primary Completion
2016-01-31
Completion
2016-01-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01541098 on ClinicalTrials.gov